Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares

Benzinga
2025.07.31 21:06
portai
I'm PortAI, I can summarize articles.

賓夕法尼亞州巴拉辛伍德，2025 年 7 月 31 日（全球新聞網絡）——Larimar Therapeutics, Inc.（“Larimar”）LRMR，一家專注於開發複雜罕見疾病治療的臨牀階段生物技術公司，今天宣佈其之前宣佈的承銷公開發行已成功完成

Source: Benzinga The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.